Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.7M Buy
35,799
+304
+0.9% +$143K 1.46% 27
2025
Q4
$15.1M Buy
35,495
+70
+0.2% +$30K 1.16% 29
2025
Q3
$16.8M Buy
35,425
+985
+3% +$466K 1.31% 25
2025
Q2
$16.2M Buy
34,440
+432
+1% +$197K 1.32% 24
2025
Q1
$15.8M Buy
34,008
+1,171
+4% +$527K 1.35% 23
2024
Q4
$13.7M Buy
32,837
+2,105
+7% +$959K 1.09% 28
2024
Q3
$14.7M Sell
30,732
-57
-0.2% -$26K 1.17% 29
2024
Q2
$13.5M Buy
+30,789
New +$13.5M 1.11% 30
2019
Q1
Sell
-2,365
Closed -$369K 101
2018
Q4
$369K Buy
+2,365
New +$374K 0.06% 77

Other funds holding LIN

Kimelman & Baird's LIN Position: Q1 2026 in Review

Kimelman & Baird increased its Linde (LIN) stake by 0.86% in Q1 2026, buying an estimated $143K and bringing the position to 35,799 shares worth $17.7M. The position accounts for 1.46% of the portfolio, ranked #27.

Kimelman & Baird first reported a position in LIN in Q4 2018 and has held it in 9 quarters since. 2,268 funds tracked by Wall St. Rank hold LIN as of Q1 2026.

  • Kimelman & Baird held 35,799 shares of Linde worth $17.7M as of Q1 2026.
  • Kimelman & Baird bought 304 Linde shares in Q1 2026, an estimated $143K.
  • Linde made up 1.46% of Kimelman & Baird's portfolio in Q1 2026, its #27 holding.
  • Kimelman & Baird first reported a position in Linde in Q4 2018 and has held it in 9 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Linde as of Q1 2026.

Based on Kimelman & Baird's 13F filing for Q1 2026, filed 13 May 2026.